Annual report pursuant to Section 13 and 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Aug. 02, 2022
Jan. 03, 2022
Feb. 16, 2021
Apr. 30, 2019
Mar. 31, 2019
Jul. 28, 2016
Dec. 31, 2022
Dec. 31, 2021
Related party payables             $ 1,077,088 $ 1,014,892
Gross proceeds from subscription agreement       $ 6,000,000        
Common share issued for services, shares             56,345 31,392
Common stock par value             $ 0.001 $ 0.001
Common Stock, Shares Issued             7,718,636 6,698,968
Ownership percentage             50.00%  
Sharebased compensation grant for services, value             $ 111,079 $ 8,715
Common share issued for services, value             $ 243,430 200,800
Lucido Subscription Agreement [Member]                
Purchase price   $ 4.35 $ 2.00          
Subscription aggregate amount receivable   $ 500,000 $ 1,125,000          
Common stock par value   $ 0.001 $ 0.001          
Common Stock, Shares Issued   114,943 562,500          
Board of Directors [Member]                
Common Stock, Shares Issued 82,500              
Sharebased compensation grant for services, shares             45,057  
Sharebased compensation grant for services, value             $ 92,973  
Common share issued for services, value $ 167,641           $ 100,000 102,500
Lucido [Member]                
Common stock par value             $ 0.001  
Directors [Member]                
Common share issued for services, value             $ 100,000 $ 102,500
Minimum [Member] | Lucido [Member]                
Ownership percentage         10.00%      
Minimum [Member] | Joseph Galligan [Member]                
Ownership percentage   10.00%         10.00%  
Minimum [Member] | Galligan Subcription [Member]                
Ownership percentage     10.00%          
Maximum [Member] | Lucido [Member]                
Ownership percentage         15.00%      
Maximum [Member] | Joseph Galligan [Member]                
Ownership percentage   15.00%         15.00%  
Maximum [Member] | Galligan Subcription [Member]                
Ownership percentage     15.00%          
BioCorRx Pharmaceuticals [Member]                
Ownership percentage held by Company           75.80%    
Non-Controlling Interest [Member]                
Ownership percentage           24.20%